Rhenium Complexes as Potential Anticancer Agents

  • ChemPubSoc Europe Logo
  • Author: Joseph D. Unsay
  • Published Date: 30 May 2017
  • Source / Publisher: Chemistry – A European Journal/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
thumbnail image: Rhenium Complexes as Potential Anticancer Agents

Related Societies

Platinum-based anticancer drugs have been at the forefront of cancer treatment. However, they are not a cure-all solution, and patients often suffer from severe side effects. In recent years, the anticancer activity of other metal complexes – mostly those containing gold and ruthenium metal centers – has been investigated. In contrast, rhenium-containing agents (e.g., complexes containing a Re(CO)3 fragment) were not studied as closely despite showing cytotoxic potential.

Peter V. Simpson and Massimiliano Massi, Curtin University, Bentley, Australia, Marco Falasca, Curtin University, Perth, Australia, and colleagues have synthesized Re(CO)3 complexes with N-heterocyclic carbene (NHC) ligands (example pictured). The team tested the activity of the complexes on the cell growth of different pancreatic cancer cell lines.

The half maximal inhibitory concentration (IC50) values of the compounds were smaller than 10 µM, similar to that of the known anticancer agent, carboplatin. These values indicate that the rhenium compounds are remarkably active against the cell lines. The team also tested similar ruthenium complexes with NHC ligands against the pancreatic cancer cell lines, but these compounds were ineffective.

The researchers tried to find the complexes' mechanism of action and showed that instead of inducing apoptosis, the compounds arrest cell cycle progression. This observation is correlated to the inhibition of Aurora-A kinase phosphorylation, which is an important checkpoint marker in cell cycle progression and a protein that is over-expressed in different tumors. According to the researchers, this class of complexes could have broad application as anticancer drugs.


Article Views: 3093

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter

A product of ChemPubSoc Europe (16 European Chemical Societies)published by Wiley-VCH